Induced Pluripotent Stem Cells: Global Markets - Product Image

Induced Pluripotent Stem Cells: Global Markets

  • ID: 4327500
  • Report
  • Region: Global
  • 139 Pages
  • BCC Research
15%OFF
until Jun 30th 2018
1 of 6
The Global Market for Induced Pluripotent Stem Cells (iPSCs) should reach $3.6 Billion in 2021, Increasing at a CAGR of 11.6% from 2016 through 2021

FEATURED COMPANIES

  • Addgene
  • Bio-Techne
  • Fate Therapeutics
  • Mello Biotechnology Inc.
  • Plasticell Ltd.
  • Reprocell Inc.
  • MORE

Report Includes

  • An overview of the global market for induced pluripotent stem cells.
  • Analyses of global market trends with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Information on induced pluripotent stem cell research products, defined as all research tools including but not limited to: induced pluripotent stem cells and various differentiated cells derived from induced pluripotent stem cells; various related assays and kits, culture media and medium components, such as serum, growth factors and inhibitors, antibodies, enzymes, and many others that can be applied for the specific purpose of executing induced pluripotent stem cell research.
  • Discussion of important manufacturers, technologies, and factors influencing market demand, such as the driving forces and limiting factors of induced pluripotent stem cell market growth.
  • Profiles of major players in the industry.

Report Scope

This study is focused on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered. For example, application-based market segments include academic research, drug development and toxicity testing, and regenerative medicine; product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis; iPSC-derived cell-type-based market segments include cardiomyocytes, hepatocytes, neurons, endothelia cells and other cell types; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also analyzed by studying the funding, patent publications and research publications in the field.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Addgene
  • Bio-Techne
  • Fate Therapeutics
  • Mello Biotechnology Inc.
  • Plasticell Ltd.
  • Reprocell Inc.
  • MORE

1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of Report
  • Methodology
  • Information Sources
  • Geographic Breakdown

2: Summary and Highlights

  • Key Drivers for Market Growth

3: Overview

  • Introduction
  • History and Current State
  • Evolution of Induced Pluripotent Stem Cell Research
  • Induced Pluripotent Stem Cell Advantages and Disadvantages
  • Technology Overview

4: Induced Pluripotent Stem Cell Applications

  • Academic Research
  • Pharmaco-Toxicological Screening
  • Drug Discovery and Development
  • Disease Modeling
  • Tissue Engineering
  • Cell Therapy

5: Induced Pluripotent Stem Cell Market Segmentation and Forecas

  • Induced Pluripotent Stem Cell Market Overview
  • Application-Based Market Overview
  • U.S. Induced Pluripotent Stem Cell Product Market
  • Induced Pluripotent Stem Cell-Derived Tissue Cell Market
  • Induced Pluripotent Stem Cell and Derivative Cell Market
  • Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
  • Induced Pluripotent Stem Cell-Derived Cell Markets by Application
  • Induced Pluripotent Stem Cell Market by Product Function
  • Research Market vs. Clinical Market
  • Application-Based Markets for Induced Pluripotent Stem Cell-Derived Cells
  • Induced Pluripotent Stem Cells and Their Derived Cells Market by Species
  • Induced Pluripotent Stem Cell Culture Markets

6: Induced Pluripotent Stem Cell Research Application Market

  • Induced Pluripotent Stem Cell Research Product Types
  • Major Players
  • Market Shares and Projections

7: Drug Discovery and Development Market

  • Product Types
  • Major Players
  • Market Shares and Projections

8: Induced Pluripotent Stem Cell Contract Service Market

  • Induced Pluripotent Stem Cell Contract Service Types
  • Major Players
  • Market Shares and Projections

9: Induced Pluripotent Stem Cell Clinical Application Market

  • Product Types
  • Regulations
  • Market Projection

10: Research Market Trend Analysis

  • Grant Analysis
  • Patent Analysis
  • Scientific Publication Analysis
  • Driving Forces

11: Clinical Application Market Trend Analysis

  • Clinical Trials
  • Driving Forces
  • Limiting Factors

12: Company Profiles

  • ABM (Applied Biological Materials Inc.)
  • Addgene
  • Allele Biotechnology And Pharmaceuticals Inc.
  • Alstem Llc
  • Applied Stemcell Inc.
  • ATCC
  • Axiogenesis AG
  • Axol Biosciencee
  • Bio-Techne
  • Bluerock Therapeutics
  • Bristol-Myers Squibb (Ipierian)
  • Cell Signaling Technology
  • Cellular Dynamics International, A Fujifilm Company
  • Corning Life Sciences
  • Creative Bioarray
  • EMD Millipore
  • Fate Therapeutics
  • Genecopoeia
  • Gentarget Inc.
  • ID Pharma Co. Ltd.
  • Invivogen
  • Lonza Group Ltd.
  • Mello Biotechnology Inc.
  • Mti-Globalstem
  • Newcells Biotech
  • Opsis Therapeutics
  • Orig3N Inc.
  • Peprotech
  • Plasticell Ltd.
  • Pluriomics B.V.
  • Primorigen Biosciences
  • Promega Corp.
  • Promocell Gmbh
  • Qiagen N.V.
  • Reprocell Inc.
  • Roslin Cell Sciences
  • Sciencell Research Laboratories
  • Sigma-Aldrich, A Part Of Milliporesigma
  • Stemcell Technologies
  • Stem Cell Theranostics Inc.
  • Stemgent Inc., A Reprocell Group Company
  • System Biosciences Inc.
  • Takara Bio USA Inc. (Clontech Laboratories)
  • Thermo Fisher Scientific
  • Viacyte Inc.
  • Waisman Biomanufacturing

13: Conclusions

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Addgene
  • Bio-Techne
  • Fate Therapeutics
  • Mello Biotechnology Inc.
  • Plasticell Ltd.
  • Reprocell Inc.
  • MORE

Analyst Credentials:

Mike Fan is a life science marketing and product management professional with more than 20 years of experience cover multiple biotech R&D areas, as well as life science marketing in both academia and industry. Mike has a broad range of technical skills in chemical and biological area and holds a PhD in Chemical Engineering and a Master of Business Administration focusing on Marketing.

Note: Product cover images may vary from those shown
5 of 6
  • ABM (Applied Biological Materials Inc.)
  • Addgene
  • Allele Biotechnology And Pharmaceuticals Inc.
  • Alstem Llc
  • Applied Stemcell Inc.
  • ATCC
  • Axiogenesis AG
  • Axol Biosciencee
  • Bio-Techne
  • Bluerock Therapeutics
  • Bristol-Myers Squibb (Ipierian)
  • Cell Signaling Technology
  • Cellular Dynamics International, A Fujifilm Company
  • Corning Life Sciences
  • Creative Bioarray
  • EMD Millipore
  • Fate Therapeutics
  • Genecopoeia
  • Gentarget Inc.
  • ID Pharma Co. Ltd.
  • Invivogen
  • Lonza Group Ltd.
  • Mello Biotechnology Inc.
  • Mti-Globalstem
  • Newcells Biotech
  • Opsis Therapeutics
  • Orig3N Inc.
  • Peprotech
  • Plasticell Ltd.
  • Pluriomics B.V.
  • Primorigen Biosciences
  • Promega Corp.
  • Promocell Gmbh
  • Qiagen N.V.
  • Reprocell Inc.
  • Roslin Cell Sciences
  • Sciencell Research Laboratories
  • Sigma-Aldrich, A Part Of Milliporesigma
  • Stemcell Technologies
  • Stem Cell Theranostics Inc.
  • Stemgent Inc., A Reprocell Group Company
  • System Biosciences Inc.
  • Takara Bio USA Inc. (Clontech Laboratories)
  • Thermo Fisher Scientific
  • Viacyte Inc.
  • Waisman Biomanufacturing
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll